Cargando…

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts**

Platinum complexes are the most widely used anticancer drugs; however, new generations of agents are needed. The organoiridium(III) complex [(η(5)-Cp(xbiph))Ir(phpy)(Cl)] (1-Cl), which contains π-bonded biphenyltetramethylcyclopentadienyl (Cp(xbiph)) and C∧N-chelated phenylpyridine (phpy) ligands, u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhe, Romero-Canelón, Isolda, Qamar, Bushra, Hearn, Jessica M, Habtemariam, Abraha, Barry, Nicolas P E, Pizarro, Ana M, Clarkson, Guy J, Sadler, Peter J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2014
Materias:	Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227564/ https://www.ncbi.nlm.nih.gov/pubmed/24616129 http://dx.doi.org/10.1002/anie.201311161

Ejemplares similares

Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C(∧)N-Chelated and Pyridine Ligands
por: Liu, Zhe, et al.
Publicado: (2014)

Organoiridium Complexes: Anticancer Agents and Catalysts
por: Liu, Zhe, et al.
Publicado: (2014)

Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands
por: Millett, Adam J., et al.
Publicado: (2015)

Ligand-centred redox activation of inert organoiridium anticancer catalysts
por: Zhang, Wen-Ying, et al.
Publicado: (2020)

Reduction of Quinones by NADH Catalyzed by Organoiridium Complexes**
por: Liu, Zhe, et al.
Publicado: (2013)

NMR studies of group 8 metallodrugs: (187)Os-enriched organo-osmium half-sandwich anticancer complex
por: Needham, Russell J., et al.
Publicado: (2021)

Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design
por: Soldevila-Barreda, Joan J., et al.
Publicado: (2015)

Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Correction to Organometallic Iridium(III) Anticancer Complexes with New Mechanisms of Action: NCI-60 Screening, Mitochondrial Targeting, and Apoptosis
por: Hearn, Jessica M., et al.
Publicado: (2013)

Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2013)

Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells
por: Zhang, Pingyu, et al.
Publicado: (2017)

Photoactivatable Cell-Selective Dinuclear trans-Diazidoplatinum(IV) Anticancer Prodrugs
por: Shi, Huayun, et al.
Publicado: (2018)

In‐Cell Activation of Organo‐Osmium(II) Anticancer Complexes
por: Needham, Russell J., et al.
Publicado: (2016)

Strategies for conjugating iridium(III) anticancer complexes to targeting peptides via copper-free click chemistry
por: Zhang, Wen-Ying, et al.
Publicado: (2019)

Nucleus‐Targeted Organoiridium–Albumin Conjugate for Photodynamic Cancer Therapy
por: Zhang, Pingyu, et al.
Publicado: (2019)

Transfer Hydrogenation and Antiproliferative Activity of Tethered Half-Sandwich Organoruthenium Catalysts
por: Chen, Feng, et al.
Publicado: (2018)

Half-Sandwich Arene Ruthenium(II) and Osmium(II) Thiosemicarbazone Complexes: Solution Behavior and Antiproliferative Activity
por: Gatti, Anna, et al.
Publicado: (2018)

New activation mechanism for half-sandwich organometallic anticancer complexes
por: Banerjee, Samya, et al.
Publicado: (2018)

Enhancement of Selectivity of an Organometallic Anticancer Agent by Redox Modulation
por: Romero-Canelón, Isolda, et al.
Publicado: (2015)

Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes
por: Venkatesh, V., et al.
Publicado: (2017)

Platinum(iv)-azido monocarboxylato complexes are photocytotoxic under irradiation with visible light
por: Shaili, Evyenia, et al.
Publicado: (2021)

Halide Control of N,N-Coordination versus N,C-Cyclometalation and Stereospecific Phenyl Ring Deuteration of Osmium(II) p-Cymene Phenylazobenzothiazole Complexes
por: Needham, Russell J., et al.
Publicado: (2017)

Os(2)–Os(4) Switch Controls DNA Knotting and Anticancer Activity
por: Fu, Ying, et al.
Publicado: (2016)

Targeting cancer lactate metabolism with synergistic combinations of synthetic catalysts and monocarboxylate transporter inhibitors
por: Bridgewater, Hannah E., et al.
Publicado: (2023)

Organometallic cis-Dichlorido Ruthenium(II) Ammine Complexes
por: Betanzos-Lara, Soledad, et al.
Publicado: (2011)

X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser
por: Bolitho, Elizabeth M., et al.
Publicado: (2020)

In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance
por: Coverdale, James P. C., et al.
Publicado: (2018)

De Novo Generation of Singlet Oxygen and Ammine Ligands by Photoactivation of a Platinum Anticancer Complex**
por: Zhao, Yao, et al.
Publicado: (2013)

Axial functionalisation of photoactive diazido platinum(iv) anticancer complexes
por: Shi, Huayun, et al.
Publicado: (2020)

Synchrotron X‐Ray Fluorescence Nanoprobe Reveals Target Sites for Organo‐Osmium Complex in Human Ovarian Cancer Cells
por: Sanchez‐Cano, Carlos, et al.
Publicado: (2017)

Comparative Cytotoxicity of Artemisinin and Cisplatin and Their Interactions with Chlorogenic Acids in MCF7 Breast Cancer Cells
por: Suberu, John O, et al.
Publicado: (2014)

Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells
por: Infante-Tadeo, Sonia, et al.
Publicado: (2021)

Easy To Synthesize, Robust Organo‐osmium Asymmetric Transfer Hydrogenation Catalysts
por: Coverdale, James P. C., et al.
Publicado: (2015)

Platinum(iv) dihydroxido diazido N-(heterocyclic)imine complexes are potently photocytotoxic when irradiated with visible light
por: Shaili, Evyenia, et al.
Publicado: (2019)

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
por: Carter, R, et al.
Publicado: (2016)

Diazido Mixed-Amine Platinum(IV) Anticancer Complexes Activatable by Visible-Light Form Novel DNA Adducts
por: Zhao, Yao, et al.
Publicado: (2013)

Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity
por: Smith, Nichola A., et al.
Publicado: (2017)

DNA‐Intercalative Platinum Anticancer Complexes Photoactivated by Visible Light
por: Shi, Huayun, et al.
Publicado: (2021)

Tracking Reactions of Asymmetric Organo‐Osmium Transfer Hydrogenation Catalysts in Cancer Cells
por: Bolitho, Elizabeth M., et al.
Publicado: (2021)

Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models
por: Medina-Gutiérrez, Esperanza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1hc7msigl07fr2btf8k9u3c5ii